to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 313 participants.
Also called NCT02056847
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 313 participants
- Sponsor
- Ajou University School of Medicine
- Asan Medical Center
- Chonbuk National University Hospital
- Chonnam National University Hospital
- Chungnam National University Hospital
- Dong-A University Hospital
- Gangnam Severance Hospital
- Hallym University Medical Center
- JW Pharmaceutical
- Korea University Guro Hospital
- Kyunghee University Medical Center
- Samsung Medical Center
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- Severance Hospital
- The Catholic University of Korea
- Ulsan University Hospital
- Yeungnam University Hospital
- Registry
-
NCT02056847
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02056847. Randomized; no masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2017-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
- Acronym
- SIPHON
- Condition
- HbA1c Level Associated With Lipid Compositions
- Intervention (Drug)
- Pitavastatin calcium 4mg
- Intervention (Drug)
- Pitavastatin calcium 2mg
- Lead sponsor
- JW Pharmaceutical
- Collaborator
- The Catholic University of Korea
- Collaborator
- Kyunghee University Medical Center
- Collaborator
- Korea University Guro Hospital
- Collaborator
- Dong-A University Hospital
- Collaborator
- Seoul National University Bundang Hospital
- Collaborator
- Samsung Medical Center
- Collaborator
- Seoul National University Hospital
- Collaborator
- Ajou University School of Medicine
- Collaborator
- Gangnam Severance Hospital
- Collaborator
- Severance Hospital
- Collaborator
- Yeungnam University Hospital
- Collaborator
- Ulsan University Hospital
- Collaborator
- Eulji University Hospital
- Collaborator
- Asan Medical Center
- Collaborator
- Chonnam National University Hospital
- Collaborator
- Chonbuk National University Hospital
- Collaborator
- Chungnam National University Hospital
- Collaborator
- Hallym University Medical Center
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 18
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 13 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 28 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.
Record details
- Record id
cardio:ct-nct02056847- Content hash
5736ceda85135d1bb54623b2e48aac61310f51ffeec2dc6f51fd2cdc3f2ad1b7